Abstract
A previously healthy 37-year-old Canadian man living in Japan visited a hospital in Thailand while traveling because of edematous legs, purpura, arthralgia, bloody stool, and fever after an insect bite. Henoch–Schönlein purpura (HSP) was suspected. His creatinine level was 5.2 mg/dL. He was treated with oral prednisolone (PSL) and oral cyclophosphamide (CPA); after treatment, his creatinine level improved to 2.4 mg/dL. Upon returning to Japan, he was admitted to the National Center for Global Health and Medicine Hospital in Tokyo. A kidney biopsy was performed, and HSP nephritis (HSPN) was diagnosed. Renal dysfunction and proteinuria persisted despite 4 administrations of steroid-pulse therapy and 3 sessions of plasma exchange. Finally, he was treated with intravenous cyclophosphamide (IVCY). His creatinine level and proteinuria markedly improved. His microscopic hematuria disappeared after he underwent tonsillectomy. There have been only a few case reports describing patients with adult-onset HSPN necessitating IVCY. We present here a rare case of steroid-resistant HSPN treated with IVCY and tonsillectomy, with reference to some recent findings.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Blanco R, Martínez-Taboada VM, Rodríguez-Valverde V, et al. Henoch-Schönlein purpura in adulthood and childhood: two different expressions of the same syndrome. Arthritis Rheum. 1997;40:859–64.
Kellerman PS. Henoch-Schönlein purpura in adults. Am J Kidney Dis. 2006;48:1009–16.
Eftychiou C, Samarkos M, Golfinopoulou S, et al. Henoch-Schönlein purpura associated with methicillin-resistant Staphylococcus aureus infection. Am J Med. 2006;119:85–6.
Atkinson SR, Barker DJ. Seasonal distribution of Henoch-Schönlein purpura. Br J Prev Soc Med. 1976;30:22–5.
Levy M, Broyer M, Arsan A, et al. Anaphylactoid purpura nephritis in children: natural history and immunology. Adv Nephrol Necker Hosp. 1976;6:183–228.
Pillebout E, Thervet E, Hill G, et al. Henoch-Schönlein purpura in adults: outcome and prognostic factors. J Am Soc Nephrol. 2002;13:1271–8.
Harries MJ, McWhinney P, Melsom R. Recurrent Henoch-Schönlein purpura controlled with ciclosporin. J R Soc Med. 2004;97:184–5.
Kusuda A, Migita K, Tsuboi M, et al. Successful treatment of adult-onset Henoch-Schönlein purpura nephritis with high-dose immunoglobulins. Intern Med. 1999;38:376–9.
Hattori M, Ito K, Konomoto T, et al. Plasmapheresis as the sole therapy for rapidly progressive Henoch-Schönlein purpura nephritis in children. Am J Kidney Dis. 1999;33:427–33.
Kauffmann RH, Houwert DA. Plasmapheresis in rapidly progressive Henoch-Schoenlein glomerulonephritis and the effect on circulating IgA immune complexes. Clin Nephrol. 1981;16:155–60.
Sugiyama H, Watanabe N, Onoda T, et al. Successful treatment of progressive Henoch-Schönlein purpura nephritis with tonsillectomy and steroid pulse therapy. Intern Med. 2005;44:611–5.
Kawasaki Y, Suyama K, Matsumoto A, et al. Efficacy of tonsillectomy plus methylprednisolone pulse therapy for a child with Henoch-Schoenlein purpura nephritis. Tohoku J Exp Med. 2007;211:291–5.
Komatsu H, Fujimoto S, Hara S, et al. Effect of tonsillectomy plus steroid pulse therapy on clinical remission of IgA nephropathy: a controlled study. Clin J Am Nephrol. 2008;3:1301–7.
Hotta O, Miyazaki M, Furuta T, et al. Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy. Am J Kidney Dis. 2001;38:736–43.
Tarshish P, Bernstein J, Edelmann CM Jr. Henoch-Schönlein purpura nephritis: course of disease and efficacy of cyclophosphamide. Pediatr Nephrol. 2004;19:51–6.
Pillebout E, Alberti C, Guillevin L, et al. Addition of cyclophosphamide to steroids provides no benefit compared with steroids alone in treating adult patients with severe Henoch-Schönlein purpura. Kidney Int. 2010;78:495–502.
Nanba T, Yamamoto T, Matsuda J, et al. An adult case of severe Henoch-Schönlein purpura associated with steroid-resistant nephrotic syndrome successfully treated with intravenous cyclophosphamide. Nihon Jinzo Gakkai Shi. 2010;52:66–72 (Article in Japanese).
López Meiller MJ, Cavallasca JA, Maliandi Mdel R, et al. Henoch-Schönlein purpura in adults. Clinics (Sao Paulo). 2008;63:273–6.
lllei GG, Austin HA, Crane M, et al. Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis. Ann Intern Med. 2001;135:248–57.
Shiiki H, Saito T, Nishitani Y, et al. Prognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Japan. Kidney Int. 2004;65:1400–7.
Hogan SL, Muller KE, Jennette JC, et al. A review of therapeutic studies of idiopathic membranous glomerulopathy. Am J Kidney Dis. 1995;25:862–75.
Mukhtyar C, Lee R, Brown D, et al. Modification and validation of the Birmingham Vasculitis Activity Score (version 3). Ann Rheum Dis. 2009;68:1827–32.
Migita K, Eguchi K, Kawabe Y, et al. Apoptosis induction in human peripheral blood T lymphocytes by high-dose steroid therapy. Transplantation. 1997;63:583–7.
Ronkainen J, Nuutinen M, Koskimies O. The adult kidney 24 years after childhood Henoch-Schönlein purpura: a retrospective cohort study. Lancet. 2002;360:666–70.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have declared that no conflict of interest exists.
Informed consent
Written informed consent was obtained from the patient for the publication of this case report and accompanying images.
About this article
Cite this article
Sasaki, E., Shibata, M., Kato, A. et al. An adult case of severe steroid-resistant Henoch–Schönlein purpura nephritis treated with intravenous cyclophosphamide and tonsillectomy. CEN Case Rep 5, 212–218 (2016). https://doi.org/10.1007/s13730-016-0227-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13730-016-0227-0